MedTrace Logo

Safety and Feasibility of Kefir Administration in Critically Ill Adults

NCT05416814 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2023-12-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and feasibility of kefir administration in critically ill adults.

Conditions

  • Critically Ill

Interventions

DIETARY_SUPPLEMENT

Kefir

Oral route (via feeding tube in intubated patients). Serving size 240mL to be given in an ascending dosing regimen if tolerated starting at 60 mL/day, 120 mL/day until single 240 mL/day; if evidence of intolerance, dose will be reduced to previously tolerated dose.

Sponsors & Collaborators

Principal Investigators

  • Lioudmila Karnatovskaia, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-12
Primary Completion
2023-02-04
Completion
2023-12-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416814 on ClinicalTrials.gov